Trang chủ › Ung thư máu › Texas › Houston
Thử nghiệm lâm sàng cho Ung thư máu tại Houston, TX
46 nghiên cứu cho Ung thư máu đang tìm kiếm người tham gia tại các cơ sở ở Houston và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Đang tuyểnGiai đoạn 1
- UT MD Anderson Cancer Center, Houston
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Đang tuyểnGiai đoạn 3
- University of Texas MD Anderson Cancer Center ( Site 0007), Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Đang tuyểnNghiên cứu quan sát
- Texas Children's Hospital, Houston
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center - University of Texas, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Đang tuyểnGiai đoạn 3
- Quetzal Site 6, Houston
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Đang tuyểnGiai đoạn 1 sớm
- M D Anderson Cancer Center, Houston
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Đang tuyểnGiai đoạn 3
- The University of Texas MD Anderson Cancer Center, Houston
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Đang tuyểnNghiên cứu quan sát
- UT MD Anderson Cancer Center, Houston
Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Đang tuyểnGiai đoạn 1
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Đang tuyểnGiai đoạn 1
- Md Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Đang tuyểnGiai đoạn 2
- The University of Texas MD Anderson Cancer Center, Houston
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
Đang tuyển
- M D Anderson Cancer Center, Houston
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Đang tuyểnGiai đoạn 2Chào đón tình nguyện viên khỏe mạnh
- M D Anderson Cancer Center, Houston
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Đang tuyểnGiai đoạn 1
- M D Anderson Cancer Center, Houston
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Đang tuyểnGiai đoạn 1/2
- MD Anderson, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Đang tuyểnGiai đoạn 3
- University of Texas, Houston
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
Đang tuyểnGiai đoạn 1/2
- M D Anderson Cancer Center, Houston
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Đang tuyểnGiai đoạn 1 sớm
- M D Anderson Cancer Center, Houston
Expressive Writing for the Management of Stress in Cancer Survivors
Đang tuyển
- M D Anderson Cancer Center, Houston
Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
The Impact of COVID-19 on Pulmonary Procedures
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- M D Anderson Cancer Center, Houston
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Đang tuyểnGiai đoạn 2
- University of Texas MD Anderson MD Anderson Cancer Center, Houston
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Đang tuyểnGiai đoạn 1
- The University of TX MD Anderson Cancer Center, Houston
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Đang tuyểnNghiên cứu quan sát
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
Improving Comprehensive Care of Cancer Patients
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Baylor College of Medicine, Houston
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- M D Anderson Cancer Center, Houston
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Đang tuyểnGiai đoạn 3
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
Đang tuyển
- M D Anderson Cancer Center, Houston
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
Đang tuyểnGiai đoạn 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Đang tuyểnGiai đoạn 1/2
- University of Texas MD Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Đang tuyểnGiai đoạn 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Thử nghiệm cho Ung thư máu tại các thành phố khác
- New York City, NY26 nghiên cứu
- Boston, MA25 nghiên cứu
- Washington, DC19 nghiên cứu
- Seattle, WA18 nghiên cứu
- Baltimore, MD18 nghiên cứu
- Los Angeles, CA17 nghiên cứu
- Durham, NC16 nghiên cứu
- Chicago, IL15 nghiên cứu
- Philadelphia, PA14 nghiên cứu
- Columbus, OH13 nghiên cứu
- Edison, NJ13 nghiên cứu
- Nashville, TN13 nghiên cứu
Các nghiên cứu khác tại Houston
- Ung thư phổi không tế bào nhỏ145 nghiên cứu
- Ung thư vú126 nghiên cứu
- Ung thư (mọi loại)121 nghiên cứu
- Ung thư di căn104 nghiên cứu
- Ung thư đại trực tràng102 nghiên cứu
- Ung thư buồng trứng89 nghiên cứu
- Bạch cầu tủy cấp85 nghiên cứu
- Ung thư phổi78 nghiên cứu
- Ung thư tuyến tiền liệt76 nghiên cứu
- Ung thư nội mạc tử cung68 nghiên cứu
- Ung thư tụy61 nghiên cứu
- Ung thư hắc tố59 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 6 thg 10, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.